Blood and stool study for advanced pancreatic cancer
Part of Cancer, Digestive system clinical trials.
This study looks at blood and stool samples from people with advanced pancreatic cancer to understand how their body's metabolism and gut bacteria affect their disease and treatment. It aims to find better ways to predict and improve treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your pancreatic cancer cannot be removed with surgery (it is either locally advanced and wrapped around important blood vessels, or it has spread to other parts of the body).
- You are about to start your first treatment for this cancer, which will be standard chemotherapy (possibly with an experimental immunotherapy agent as part of another study).
- You are generally well enough to be up and about for at least half of your waking hours (performance status 0-2), and your kidney, liver, and blood counts are good enough to handle treatment.
- You are willing to provide blood and stool samples for the study.
- You have not had any previous chemotherapy or other systemic treatment for this pancreatic cancer.
- You are not currently on long-term antibiotics or probiotics (or you are willing to pause them for the study), and you do not have another active cancer that could interfere with the results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks if a simple blood test can find tiny bits of cancer DNA after your pancreatic surgery, which may help detect if cancer comes back earlier than scans. By joining, you'll help doctors learn how to better monitor the disease and guide future treatments.
This study looks at a scoring system to predict how well people with advanced pancreatic cancer might do after their first chemotherapy. If you have been diagnosed with this type of cancer and are about to start or have just finished your first treatment, this study may be able to use your health information to help guide future care.
This study looks at advanced or metastatic pancreatic cancer patients and uses stored tumor tissue to learn what may predict treatment outcomes. You may be able to join if you have had limited prior chemotherapy and can provide an archived tissue sample.
This study looks at blood samples from people with early-stage pancreatic cancer to understand how the immune system behaves. The goal is to find better treatments. If you have pancreatic cancer that hasn't spread, they may ask you to donate blood for research.
This study is looking at genetic material and proteins from pancreatic tumors to understand how the cancer responds to treatment. It aims to help doctors choose the best therapies for patients with certain types of pancreatic cancer that can be removed surgically or that have not spread to other organs.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
Hear when a new Pancreatic Ductal Adenocarcinoma (PDAC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.